Cart
sales@molnova.com
Phosphonoformic acid trisodium salt hexa
CAS No. 34156-56-4
Phosphonoformic acid trisodium salt hexa( foscarnet sodium hexahydrate | Sodium phosphonatoformate hexahydrate )
Catalog No. M28595 CAS No. 34156-56-4
Phosphonoformic acid trisodium salt hexa is an antiviral drug for the treatment of CMV retinitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 26 | In Stock |
|
Biological Information
-
Product NamePhosphonoformic acid trisodium salt hexa
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhosphonoformic acid trisodium salt hexa is an antiviral drug for the treatment of CMV retinitis.
-
DescriptionPhosphonoformic acid trisodium salt hexa is an antiviral drug for the treatment of CMV retinitis.
-
In VitroFoscarnet sodium (Phosphonoformic acid) inhibit the human cytomegalovirus DNA polymerase (UL54) by mimicking the pyrophosphate leaving group of the nucleotide transfer reaction.Foscarnet sodium (Trisodium phosphonoformate) inhibits Influenza A Victoria (IC50=29 μM), Influenza B HK (IC50=61 μM), and Avian myeloblastosis virus (IC50=5-8 μM), HSV-1, several strains (IC50=0.4-3.5 μM).
-
In Vivo——
-
Synonymsfoscarnet sodium hexahydrate | Sodium phosphonatoformate hexahydrate
-
PathwayOthers
-
TargetOther Targets
-
Recptorα1-adrenoceptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number34156-56-4
-
Formula Weight126.01
-
Molecular FormulaCH3O5P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(P(O)(O)=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Roquebert J, et al. Inhibition of the alpha 1 and alpha 2-adrenoceptor-mediated pressor response in pithed rats by raubasine, tetrahydroalstonine and akuammigine. Eur J Pharmacol. 1984 Oct 30;106(1):203-5.
molnova catalog
related products
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
-
Heteroclitin G
Heteroclitin G was found as potential biomarkers of KIS blood-replenishing activity, and quantitative analysis provided a research basis for further pharmacological research.
-
LL - 37, reverse seq...
LL - 37, reverse sequence
